Roche gets Indian regulator’s nod for antibody cocktail to treat covid-19

The authorisation in India will allow Roche to import the manufactured batches of the antibody cocktail of casirivimab and imdevimab, which will be marketed and distributed in India through a strategic partnership with Cipla Ltd